Human Molecular GeneticsMolecular BiologyPeer-reviewed journal article
A discrete region of the D4Z4 is sufficient to initiate epigenetic silencing
Ellen PaatelaiD, Faith G St. Amant, Danielle C. HammiD, Sean R. BennettiD, Taranjit S. GujraliD, Silvère M. van der MaareliD, Stephen J. TapscottiD
Abstract
The DUX4 transcription factor is briefly expressed in the early embryo and is epigenetically repressed in somatic tissues. Loss of epigenetic repression can result in the aberrant expression of DUX4 in skeletal muscle and can cause facioscapulohumeral dystrophy (FSHD). Multiple factors have been identified as necessary to maintain epigenetic silencing of DUX4 in skeletal muscle, but whether specific sequences at the DUX4 locus are sufficient for epigenetic silencing has been unknown. We cloned fragments of the D4Z4 macrosatellite repeat, the DNA region that encompasses the DUX4 retrogene, adjacent to a reporter driven by a constitutive promoter and identified a single fragment sufficient to epigenetically repress reporter gene expression. Previously identified suppressors of DUX4 expression--SETDB1, ATF7IP, SIN3A/B, and LRIF1--were necessary for silencing activity and p38 inhibitors enhanced suppression. These findings identify a key regulatory sequence for D4Z4 epigenetic repression and establish a model system for mechanistic and discovery studies.
- Citations
- 1
- FWCI
- 0.30
- Field percentile
- 48th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Hit-and-run silencing of endogenous DUX4 by targeting DNA hypomethylation on D4Z4 repeats in facioscapulohumeral muscular dystrophy
M. Sasaki-Honda, T. Jonouchi, … H. Sakurai·bioRxiv·Apr 12, 2022
- Developmental regulators drive DUX4 expression in facioscapulohumeral muscular dystrophy
Amelia Fox, Jonathan Oliva, … Francis M. Sverdrup·bioRxiv·May 21, 2024
- Chemical inhibition of SUMOylation activates the FSHD locus
Alice Nordlinger, Loéva Morin, … Frédérique Magdinier·Scientific ReportsPeer-reviewed·Jan 9, 2026
- In vitro and in silico characterization of competitive inhibition and repression of DUX4 target gene activation as a therapeutic approach for facioscapulohumeral muscular dystrophy (FSHD)
Heloise M. Hoffmann, Alice Finkelstein, … Phillip Kyriakakis·bioRxiv·Aug 20, 2026
- BAZ1A promotes expression of DUX4-fl and its lncRNA activator DBE-T in facioscapulohumeral muscular dystrophy
Ning Chang, Takako Iida Jones, … Charis L. Himeda·bioRxiv·Jun 19, 2026
- Transgenic mouse models for investigating human DUX4 expression during development and its roles in FSHD pathophysiology
Yosuke Hiramuki, Charis L. Himeda, … Takako Iida Jones·Disease Models & MechanismsPeer-reviewed·Apr 7, 2026